Email Alert | RSS    帮助

中国防痨杂志 ›› 2019, Vol. 41 ›› Issue (8): 843-847.doi: 10.3969/j.issn.1000-6621.2019.08.008

• 论著 • 上一篇    下一篇

手术治疗结核性脓胸并发静止期肝硬化患者的疗效分析

任航空(),段李明,张毅,胡明军   

  1. 710061西安市胸科医院外科
  • 收稿日期:2019-04-24 出版日期:2019-08-10 发布日期:2019-08-13
  • 通信作者: 任航空 E-mail:271415955@qq.com
  • 基金资助:
    西安市卫生和计划生育委员会卫生科研人才培训项目(J201902023)

Efficiency analysis of surgical treatment in patients suffering tuberculous empyema complicated with static cirrhosis

Hang-kong REN(),Li-ming DUAN,Yi ZHANG,Ming-jun HU   

  1. Department of Surgical,Xi’an Chest Hospital, Xi’an 710061, China
  • Received:2019-04-24 Online:2019-08-10 Published:2019-08-13
  • Contact: Hang-kong REN E-mail:271415955@qq.com

摘要:

目的 探讨手术治疗结核性脓胸并发静止期肝硬化患者的疗效。方法 收集2013年4月至2018年4月西安市胸科医院收治的36例结核性脓胸并发静止期肝硬化患者,行结核性脓胸病灶清除、纤维板剥脱术。对患者的手术时间、术中出血量、术后引流量、拔管时间、肺部并发症、术后住院天数、肺功能变化进行分析。结果 本组患者术中出血量、术后3天总引流量、术后拔胸管时间、术后胸腔感染率分别为(423.6±32.8)ml、 (664.8±49.9)ml、 (5.6±1.2)d、16.7%(6/36)。本组患者术后3个月肺功能指标用力肺活量(FVC)为(90.6±8.6)%;第1秒用力呼气容积(FEV1)为(85.0±6.6)%;用力呼气峰流速(PEF)为(72.9±2.7)%;最大自主通气量(MVV)为(84.7±4.4)%,与术前[分别为(68.9±7.5)%、(63.5±5.6)%、(64.1±3.6)%、(61.6±4.1)%]比较,差异均有统计学意义(t=-11.37, P<0.01;t=-10.94, P<0.01;t=-13.36,P<0.01;t=-21.14, P<0.01)。36例患者均获得9个月随访,症状消失,34例伤口一期愈合;2例伤口延迟愈合,局部换药1个月后愈合。无复发患者。结论 手术治疗静止性肝硬化并发结核性脓胸安全性、可行性、疗效均较好,未出现肝硬化活动及结核播散情况,但对于术中渗血及手术引流量值得引起警惕。

关键词: 肝硬化, 脓胸, 结核性, 胸外科手术, 治疗结果

Abstract:

Objective To evaluate the efficacy of surgical treatment of tuberculous empyema complicated with static cirrhosis.Methods Thirty-six patients who were suffering from tuberculous empyema complicated with static cirrhosis were enrolled from April 2013 to April 2018 in Xi’an Chest Hospital. The tuberculous empyema lesions were removed and the pleural resection was performed. The patient’s operation time, intraoperative blood loss, postoperative drainage volume, tube time, pulmonary complications, postoperative hospitalization time, and lung function changes were analyzed.Results The intraoperative blood loss, total 3 days postoperative drainage volume, postoperative tube time, and postoperative chest infection rate were (423.6±32.8)ml, (664.8±49.9)ml, (5.6±1.2)d, 16.7% (6/36). The postoperative pulmonary function index after 3 months were following: the forced vital capacity (FVC) was (90.6±8.6)%; the first expiratory volume (FEV1) was (85.0±6.6)%; the maximum expiratory peak flow rate (PEF) was (72.9±2.7)%; the ventilation volume (MVV) was (84.7±4.4)%, compared with the preoperative index ((68.9±7.5)%, (63.5±5.6)%, (64.1±3.6)%, (61.6±4.1)%), the difference was statistically significant (t=-11.37, P<0.01; t=-10.94, P<0.01; t=-13.36, P<0.01; t=-21.14, P<0.01). Thirty-six patients were followed up for 9 months and the symptoms disappeared; 34 wounds healed by first intention, 2 cases delayed healing and healed after 1 month with local dressing change. No recurrence patients.Conclusion Surgical treatment of static cirrhosis with tuberculous empyema is safe, feasible and effective. There is no cirrhosis activity and tuberculosis dissemination, but intraoperative blood loss and postoperative drainage volume should be vigilant.

Key words: Liver cirrhosis, Empyema, tuberculous, Thoracic surgical procedures, Treatment outcome